Ziegler EJ, McCutchan JA, Fierer J. et al. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med1982; 307: 1225-1230.
2.
Ziegler EJ, Fisher CJ Jr, Sprung CL et al and the HA-1A Sepsis Study Group. Treatment of gram-negative bacteremia in septic shock with HA-1A human monoclonal antibody against endotoxin; a randomized, double-blind, placebo-controlled trial. N Engl J Med1991; 324: 429-436.
3.
Greenman RL, Schein Rmh, Martin MA et al. A controlled clinical trial of ES murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA1991: 266: 1097-1102.
4.
McCloskey RVHA-1A efficacy and septic shock (CHESS) trial results. The 3rd Annual Meeting on: Advances in the diagnosis, prevention and treatment of endotoxemia and sepsis, Philadelphia, 18 June, 1993. International Business Communications1993; 119-123.
5.
Wenzel R., Bone R., Fein A. et al. Results of s second double-blind, randomized, controlled trial of antiendotoxin antibody E5 in gram-negative sepsis. Program and abstracts of the 31 st Interscience Conference on: Antimicrobial agents and chemotherapy, 1991; 294(Abstract 1170).
6.
Cross AS, Opal S.Therapeutic intervention in sepsis with antibody to endotoxin: is there a future?J Endotoxin Res1994; 1: 57-69
